Smoking and coronary atherosclerosis: follow-up study in China

En-Zhi Jia1, Jun Liang, Zhi-Jian Yang

  • 1Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. enzhijia@yahoo.cn

Insights

Smoking significantly worsens coronary atherosclerosis severity and increases mortality risk. Lifetime cigarette consumption is a key predictor of both disease progression and all-cause mortality in patients with atherosclerosis.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary atherosclerosis is a leading cause of mortality worldwide.
  • The cumulative impact of cigarette smoking on coronary atherosclerosis severity and patient outcomes requires further investigation.

Purpose of the Study:

  • To investigate the association between lifetime cigarette consumption and the severity of coronary atherosclerosis.
  • To determine if smoking is an independent risk factor for mortality in patients with coronary atherosclerosis.

Main Methods:

  • A cohort of 1096 patients undergoing coronary angiography was analyzed.
  • Coronary atherosclerosis severity was quantified using the Gensini score.
  • Smoking history was estimated, and associations with clinical and laboratory parameters, including mortality, were assessed using multivariate analysis.

Main Results:

  • Higher cigarette consumption correlated positively with Gensini score, pro-insulin, and inflammatory markers (leukocyte and neutrophil counts).
  • Inverse correlation was observed between smoking and High-density lipoprotein-cholesterol levels.
  • Lifetime smoking was an independent predictor of all-cause mortality, with a hazard ratio of 1.328 over a median follow-up of 2.86 years.

Conclusions:

  • Lifetime cigarette smoking is a significant predictor of coronary atherosclerosis severity.
  • Smoking is an independent risk factor for mortality in individuals with coronary atherosclerosis, highlighting the need for smoking cessation interventions.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...